NCT07166380 - RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 20, 2025

Primary Completion Date

February 20, 2026

Study Completion Date

May 19, 2026

Conditions

Transcranial Bone Marrow InjectionRK-4Acute Large Hemispheric InfarctionAcute Ischemic Stroke

Interventions

DRUG

RK-4 injection

patients with LHI will take drug RK-4 (1 mg or 2 mg or 4 mg) by transcranial bone marrow injection once daily for consecutive 3 days.

Trial Locations (1)

Beijing TianTan Hospital, Beijing